Dec 9, 2018, 01:00 by admin admin

ASAM submitted comments to the Food and Drug Administration (FDA) in response to a request for comment ahead of a public advisory committee meeting regarding strategies to increase the availability of naloxone products intended for use in the community.

Dec 6, 2018, 01:00 by admin admin

ASAM has released a set of evidence-informed policy recommendations for preventing alcohol and drug-related problems in contemporary society. The policy recommendations were approved by the ASAM Board of Directors and have been endorsed by the American College of Preventive Medicine.

Oct 24, 2018, 01:00 by admin admin

The leading association for addiction treatment professionals noted that while H.R. 6 is a critical step toward stemming the nation’s opioid overdose epidemic, more work remains to ensure that patients receive whole-person, evidence-based treatment for opioid use disorder.

Oct 15, 2018, 01:00 by admin admin

The American Society of Addiction Medicine (ASAM) applauds the House of Representatives for its action this week to pass the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (H.R. 6), the Overdose Prevention and Patient Safety (OPPS) Act (H.R. 6082), and the IMD Care Act (H.R. 5797).

Oct 15, 2018, 01:00 by admin admin

Legislation is an Important Step Forward to Close the Addiction Treatment Gap and Teach, Standardize, and Cover Addiction Medicine

Oct 3, 2018, 01:00 by admin admin

The American Society of Addiction Medicine (ASAM) today applauds US House and Senate leaders for announcing a bipartisan agreement on an opioid legislative package that includes key provisions to bolster the country’s addiction treatment workforce, help provide standardized evidence-based treatment for individuals with a substance use disorder (SUD), and help ensure coverage and payment models facilitate comprehensive, coordinated care for patients seeking treatment for a SUD.

Oct 3, 2018, 01:00 by admin admin

During ASAM’s 2018 Annual Conference, ASAM’s Board of Directors approved of three new policy statements: Prescription Drug Monitoring Programs (PDMPs), E-Cigarettes, and the Role of Recovery in Addiction Care.

Oct 3, 2018, 01:00 by admin admin

The American Society of Addiction Medicine (ASAM) applauds the House Energy and Commerce Subcommittee on Oversight and Investigations for reviewing advertising and marketing practices of addiction treatment programs in the United States (US) in its hearing titled “Examining Advertising and Marketing Practices within the Substance Use Treatment Industry.” The hearing is part of Congress’s ongoing effort to ensure addiction treatment facilities abide by appropriate standards and provide evidence-based treatment.

Oct 3, 2018, 01:00 by admin admin

On May 14, the Department of Justice’s (DOJ) issued a settlement agreement which found that Charlwell House,  a skilled nursing facility, violated the Americans with Disabilities Act (ADA) by refusing to accept a patient for treatment because the patient was being treated with Suboxone for opioid use disorder (OUD).

Sep 14, 2018, 01:00 by admin admin

Sep 14, 2018, 01:00 by admin admin

ASAM and MISAM submitted a letter of opposition to HB4404 and HB4405. These bills would create barriers to accessing treatment for addiction.

Sep 14, 2018, 01:00 by admin admin

ASAM responds to a Request For Information (RFI) released by the Centers for Medicare and Medicaid Services (CMS) regarding their new direction for innovation.

Sep 14, 2018, 01:00 by admin admin

The Mental Health Liaison Group is writing to express support the Excellence in Mental Health and Addiction Treatment Expansion Act (S. 1950/H.R.3931) -  legislation to expand the Certified Community Behavioral Health Center (CCBHC) demonstration program authorized in Section 223 of the Protecting Access to Medicare Act that is based on your Excellence in Mental Health Act.

Sep 14, 2018, 01:00 by admin admin

ASAM is pleased to offer a letter of support for S. 2589, the Comprehensive Opioid Recovery Act, introduced by Shelly Moore Capito (ME) and Senator Maggie Hassan (NH). This legislation will create competitive grants to operate Comprehensive Opioid Recovery Centers that provide a full range of treatment and recovery services, such as medication assisted treatment, recovery housing, job training and supported reintegration into the workforce, counseling, and community-based and peer recovery support services.

Sep 14, 2018, 01:00 by admin admin

Sep 14, 2018, 01:00 by admin admin

Yesterday, President Trump’s Commission on Combating Drug Addiction and the Opioid Epidemic held its fifth and final meeting during which the commission approved its final report to the president.

Sep 14, 2018, 01:00 by admin admin

Today, the American Society of Addiction Medicine (ASAM) applauded U.S. Surgeon General Jerome M. Adams, MD, MPH, for encouraging more individuals, including family, friends, and those at risk for opioid overdose, to keep on hand naloxone, an FDA-approved medication that can reverse opioid-induced respiratory depression.

Sep 14, 2018, 01:00 by admin admin

ASAM and the Ohio Society of Addiction Medicine (OHSAM) sent a letter to the State of Ohio Board of Pharmacy and the Department of Mental Health and Addiction Services asking them to provide education and clarity to providers of office-based opioid treatment (OBOT) on new proposed rules.

Sep 14, 2018, 01:00 by admin admin

Yesterday, President Donald J. Trump directed the declaration of a Nationwide Public Health Emergency to address the country’s opioid crisis. The American Society of Addiction Medicine (ASAM) applauds President Trump for taking this historic step.

Sep 14, 2018, 01:00 by admin admin

ASAM applauds Senator Maggie Hassan (D-NH) and Rob Portman (R-OH) for introducing the Enhancing Access to Addiction Treatment Act of 2018. This legislation would establish a new pathway to obtain a DATA waiver and train more new physicians to prescribe medication-assisted treatment.